The BIO CEO conference will have a panel discussion on RNAi. (Fortunately, it doesn’t conflict with the “The Eyes have It” panel, which is the following day):
>> Sirna Therapeutics, Inc. (Nasdaq: RNAI - News) today announced that it will participate in a focus session titled, "What's All the Fuss About RNAi?" at the 6th Annual BIO CEO & Investor Conference on February 24, 2004 at 9:30 AM <<
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”